Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
D09DIG
|
||||
| Former ID |
DIB016004
|
||||
| Drug Name |
Ablukast
|
||||
| Synonyms |
Ablukast sodium; RO-23-3544
|
||||
| Drug Type |
Small molecular drug
|
||||
| Indication | Asthma [ICD10:J45] | Discontinued in Phase 3 | [545175] | ||
| Company |
Roche Holding AG
|
||||
| Formula |
C28H34O8
|
||||
| Canonical SMILES |
c1(c(ccc(c1CCC)OCCCCCOc1c(cc2c(OC(C(=O)O)CC2)c1)C(=O)C)<br />C(=O)C)O
|
||||
| PubChem Compound ID | |||||
| Target and Pathway | |||||
| Target(s) | Cysteinyl leukotriene receptor 1 | Target Info | Modulator | [1572591] | |
| Pathway Interaction Database | Endothelins | ||||
| References | |||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Tang and Dr. Zhang.